Drugs / DHEA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00972023 | Feb → Mar 2010 | breast cancer | Barbara Ann Karmanos Cancer Institute | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DHEA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00972023 ↗ |
| Modality | Small molecule | “the adrenal steroid, dehydroepiandrosterone (DHEA)” NCT00972023 ↗ |
| Route | Oral | “Patients receive oral dehydroepiandrosterone (DHEA) twice daily” NCT00972023 ↗ |